Gary L. Wilson

Experience

  • Robins Kaplan LLP, 1986-present.
  • Practice focuses on complex litigation, including plaintiff-side product liability matters, commercial disputes, and appellate litigation.

Plaintiffs' Co-Lead Counsel in Abilify Multi-District Litigation

Counsel in In re Chantix Litigation MDL. Represented plaintiffs and developed experts in products liability action leading to a global settlement. 

Counsel in Charbonneau v. Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer, Inc..  Represented plaintiffs in first Mirapex products liability bellwether trial.  On July 30, 2008, jury returned a verdict in favor of plaintiffs for $8,279,300, including $7.8 million in punitive damages for failing to warn of risk of compulsive behaviors, including pathological gambling, from the Parkinson's drug Mirapex.  

Counsel in Zwayer v. Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer, Inc..  Represented plaintiffs in second Mirapex bellwether trial.  Case was confidentially settled prior to closing argument.

One of the partners heading the firm's litigation on behalf of persons injured by Vioxx.

One of the partners leading the firm's litigation representing clients injured by the St. Jude mechanical heart valve.

One of the attorneys who represented the State of Minnesota and Blue Cross Blue Shield of Minnesota against the tobacco industry.

Worked on the litigation concerning the defective Bjork-Shiley artificial heart valve.

One of the attorneys who represented the Government of India against Union Carbide regarding the Bhopal India gas disaster.

Best Law Firms 2015
  • Named a “2013 Top Rated Lawyer in Mass Torts,” American Lawyer
  • Named a "Litigation Star," Benchmark Litigation (2013, 2016 editions)
  • Recognized as “AV-Preeminent” by Martindale-Hubbell
Bar Admissions
  • California
  • Minnesota
  • Wisconsin
  • U.S. Court of Appeals, Eighth Circuit
  • U.S. Court of Appeals, Fourth Circuit
  • U.S. Court of Appeals, Ninth Circuit
  • U.S. Court of Appeals, Third Circuit
  • U.S. District Court, District of Colorado
  • U.S. District Court, Minnesota
  • U.S. Supreme Court
  • U.S. District Court, Eastern District of California
  • U.S. District Court, Eastern District of Wisconsin
  • U.S. District Court, Southern District of Indiana
Education
  • University of Wisconsin Law School, J.D., with honors, Order of the Coif (1986); Articles Editor, Wisconsin Law Review
  • University of Wisconsin, B.A.
Professional Associations
  • American Law Institute, Elected Member
  • American Law Institute, Consultant Group of Aggregate Litigation
  • American Law Institute, Consultant Group on Tort Law
  • American Association for Justice
  • Minnesota Association for Justice
  • International Bar Association
  • Minnesota State Bar Association (Food and Drug Committee)

  • Benicar Settlement Update
    Mass Torts Made Perfect, Las Vegas, Nevada (October 19, 2017)
  • Hypothetical Ethics Exercise: Preserving Privilege in a Food, Drug or Medical Device Case
    Panelist, HB Litigation Conference: Food, Drug and Medical Device Litigation Forum, Minneapolis, Minnesota (April 24, 2012)
  • Ghostwriters, Buried Data and Other Big Pharma Tricks: Tools and Dissecting and Revealing Errors in Published Clinical Drug Trials
    Minnesota Association for Justice, Alexandria, Minnesota (August 13, 2011)
  • Hypothetical Ethics Exercise Preserving Privilege in a Food Drug or Medical Device Case
    Minnesota Institute of Legal Education, Minneapolis, MN (May 22, 2003)
  • Hypothetical Ethics Exercise Preserving Privilege in a Food Drug or Medical Device Case
    Faculty Presenter, Minnesota Trial Lawyers' Association, Minneapolis, MN (May 14, 1999)
  • Hypothetical Ethics Exercise Preserving Privilege in a Food Drug or Medical Device Case
    Minnesota Law and Politics, Minneapolis, MN (April 11, 1999)
  • Hypothetical Ethics Exercise Preserving Privilege in a Food Drug or Medical Device Case
    Faculty Presenter, Minnesota Law and Politics, Minneapolis, MN (September 8, 1997)
Back to Top